Caitong International Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,213
Closed -$62.6K – 3216
2026
Q1
$62.6K Sell
1,213
-3,020
-71% -$211K 0.01% 713
2025
Q4
$390K Buy
4,233
+3,153
+292% +$302K 0.1% 109
2025
Q3
$80.1K Buy
1,080
+1,060
+5,300% +$107K 0.06% 213
2025
Q2
$2.6K Buy
20
+9
+82% +$1.3K ﹤0.01% 1296
2025
Q1
$1.75K Sell
11
-82
-88% -$14.8K ﹤0.01% 1403
2024
Q4
$17.2K Buy
+93
New +$18.1K 0.02% 837

Other funds holding INSP

Caitong International Asset Management's INSP Position: Q2 2026 in Review

Caitong International Asset Management sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 1,213 shares — an estimated $62.6K sold.

Caitong International Asset Management first reported a position in INSP in Q4 2024 and held it in 6 quarters. The position peaked at $390K in Q4 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Caitong International Asset Management reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 1,213 Inspire Medical Systems shares in Q2 2026, an estimated $62.6K.
  • Caitong International Asset Management first reported a position in Inspire Medical Systems in Q4 2024 and held it in 6 quarters.
  • Caitong International Asset Management's Inspire Medical Systems position peaked at $390K in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.